Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage wi

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:llww6
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To evaluate the utility of local tumor therapy combined with percutaneous transhepatic biliary drainage (PTBD) for malignant obstructive biliary disease.METHODS: A total of 233 patients with malignant biliary obstruction were treated in our hospital with PTBD by placement of metallic stents and/or plastic tubes. After PTBD, 49 patients Accepted: brachytherapy or extraradiation therapy or arterial infusion chemotherapy. The patients were followed up with clinical and radiographic evaluation. The survival and stent patency rate were calculated by Kaplan-Meier survival analysis.RESULTS: Twenty-two patients underwent chemotherapy (11 cases of hepatic carcinoma, 7 cases of pancreatic carcinoma, 4 cases of metastatic lymphadenopathy), and 14 patients received radiotherapy (10 cases of cholangiocarcinoma, 4 cases of pancreatic carcinoma), and 13patients Accepted: brachytherapy (7 cases of cholangiocarcinoma, 3 cases of pancreatic carcinoma, 4 cases of metastatic lymphadenopathy). The survival rate of the local tumor treatment group at 1, 3, 6, and 12 months was 97.96%, 95.92%, 89.80%, and 32.59% respectively,longer than that of the non treatment group. The patency rate at 1, 3, 6, and 12 months was 97.96%, 93.86%,80.93%, and 56.52% respectively. The difference of patency rate was not significant between treatment group and non treatment group.CONCLUSION: Our results suggest that local tumor therapy could prolong the survival time of patients with malignant biliary obstruction, and may improve stent patency.
其他文献
目的探讨急性胰腺炎(AP)患者的心理健康状况及其影响因素。方法选取2018年12月至2019年2月间海军军医大学附属长海医院收治的AP患者,按数字表法随机抽取120例,采用自制的一般情况调查表、抑郁自评量表、焦虑自评量表、应对方式评定量表进行问卷调查,评定患者的心理健康状况,并进行统计学分析。结果收回有效问卷109份,其中抑郁发生率为44.0%,焦虑发生率为20.2%。男性患者的焦虑、抑郁水平显著
目的研究高渗预充液体外循环对冠状动脉旁路移植术患者术后早期血管外肺水以及心肺功能的影响。方法回顾性分析择期接受冠状动脉旁路移植术治疗患者82例的临床资料,按照给予的预冲液不同分为对照组(给予晶体预冲液)和研究组(给予高渗预冲度),每组41例。观察术中、术后指标,不同时间点血浆胶体渗透浓度(COP)及心肺功能指标的变化情况。结果研究组预充液COP明显高于对照组[(42.16±12.26)mmol/L
AIM: To analyze the hemodynamic and respiratory effects of propofol on patients undergoing gastroscopy and colonoscopy.METHODS: In this prospective study, condu
总结对1例膀胱肿瘤患者植入输尿管外支架的护理经验,通过从患者的疾病以及心理等多方面因素进行全面的护理以达到最好的护理效果,从而改善患者的预后和生存质量.
目的 探析对先天性房间隔缺损患者行以完全胸腔镜与传统开胸手术治疗的疗效差异.方法 择取52例先天性房间隔缺损患者,将其随机分成两组,对照组26例患者行以传统开胸手术治疗,
目的观察康柏西普在增生性糖尿病性视网膜病变(PDR)术前应用的最佳时机。方法回顾性分析2017年5月至2018年7月PDR进行玻璃体切除术75例(75眼),随机分为A、B两组,A组38例(38眼),于术前7天玻璃体内注射康柏西普;B组37例(37眼),于术前3天玻璃体内注射康柏西普。观察比较两组手术耗时、术中术后并发症和术后6个月的视力。结果两组患者术后视力均较术前明显提高(t=8.854,P=0
期刊
目的探讨胆管癌的表遗传学改变.方法用甲基化特异PCR(MSP)法,检测了12个候选肿瘤抑制基因(APG E-cadherin/CDH1,MGMT,RASSF1A,GSTP,RAR-β,p14ARF,p15INK4b,p16INK4a,p73,hML
目的评价玻璃体切除术联合康柏西普治疗增生型糖尿病视网膜病变(PDR)的临床效果。方法前瞻性病例对照研究。2016年10月至2017年12月收治的PDR 62例(86眼),随机分为两组:单纯玻璃体切除术31例(41眼)为对照组,玻璃体切除术联合康柏西普玻璃体内注射31例(45眼)为联合组。术前、术后3个月和6个月检测最佳矫正视力(BCVA)、黄斑视网膜厚度以及黄斑中心区厚度(CMT),并记录并发症情
目的 分析2型糖尿病早期肾损害的彩色多普勒超声诊断价值.方法 选择我院2016年3月-2019年3月收治的200例2型糖尿病患者作为研究对象,按照24h尿蛋白定量不同将惠者分为ABC三组